4//SEC Filing
Mostafa Adam S. 4
Accession 0001628280-24-010279
CIK 0001501697other
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 5:19 PM ET
Size
5.3 KB
Accession
0001628280-24-010279
Insider Transaction Report
Form 4
Mostafa Adam S.
Chief Financial Officer
Transactions
- Sale
Common Stock
2024-03-11$0.88/sh−52,500$46,347→ 0 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $0.8649 to $0.9147, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
X4 Pharmaceuticals, Inc
CIK 0001501697
Entity typeother
Related Parties
1- filerCIK 0001738081
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 8:00 PM ET
- Accepted
- Mar 11, 5:19 PM ET
- Size
- 5.3 KB